Optimization of the beta-aminoester class of factor Xa inhibitors. Part 2: Identification of FXV673 as a potent and selective inhibitor with excellent In vivo anticoagulant activity.
Bioorg Med Chem Lett
; 12(12): 1671-4, 2002 Jun 17.
Article
in En
| MEDLINE
| ID: mdl-12039587
ABSTRACT
Further optimization of the beta-aminoester class of factor Xa (fXa) inhibitors is described culminating in the identification of 9c (FXV673), a potent and selective factor Xa inhibitor with excellent in vivo anticoagulant activity. An X-ray structure of FXV673 bound to human fXa is also presented. Based on its selectivity, potent in vivo activity and favorable pre-clinical safety profile, FXV673 was selected for further development and is currently undergoing clinical trials.
Search on Google
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pyridines
/
Serine Proteinase Inhibitors
/
Cyclic N-Oxides
/
Factor Xa Inhibitors
/
Anticoagulants
Type of study:
Diagnostic_studies
/
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
Bioorg Med Chem Lett
Journal subject:
BIOQUIMICA
/
QUIMICA
Year:
2002
Document type:
Article
Affiliation country: